Showing 1 - 2 results of 2 for search 'Beate Rohde', query time: 0.01s Refine Results
  1. 1
    Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study

    Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study by Klaus Francke, Sybille Baumann, Isabella Gashaw, Stefan Klein, Beate Rohde, Oliver Zolk, Oliver M. Fischer, Christian Friedrich

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies

    Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies by Maximilian Feldmüller, Stefan J. Jodl, Bart Ploeger, Andrea Wagenfeld, Herbert Wiesinger, Frank S. Zollmann, Stefan Klein, Ruiping Zhang, Beate Rohde, Joachim Höchel

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: